ZC3H14 inhibitors are a class of chemical compounds designed to specifically target zinc finger CCCH-type containing protein 14 (ZC3H14), an RNA-binding protein involved in the regulation of RNA stability, processing, and gene expression. ZC3H14 is part of a family of CCCH-type zinc finger proteins, characterized by the presence of zinc finger motifs that allow the protein to bind to RNA molecules and influence their fate within the cell. These motifs are stabilized by the coordination of zinc ions, which maintain the protein's structure and enable its interaction with specific RNA sequences. ZC3H14 is implicated in the regulation of polyadenylation, RNA splicing, and possibly RNA degradation, making it a critical player in post-transcriptional gene regulation. Inhibitors of ZC3H14 function by disrupting its RNA-binding capacity or by interfering with its involvement in RNA regulatory complexes, which affects the processing, stability, and turnover of RNA in the cell.
The mechanisms by which ZC3H14 inhibitors operate can vary depending on their chemical structure and mode of action. One common mechanism involves targeting the zinc finger motifs, which are essential for RNA binding. These inhibitors may chelate the zinc ions required for maintaining the structural integrity of the zinc finger domains, causing the protein to lose its ability to bind RNA. Without this interaction, ZC3H14 cannot regulate the RNA molecules that depend on its binding for stability or proper processing. Other inhibitors may disrupt protein-protein interactions that are critical for ZC3H14's function within larger RNA-protein complexes. By preventing these interactions, the inhibitors impair ZC3H14's ability to regulate RNA-related processes such as polyadenylation or splicing. Research into ZC3H14 inhibitors provides valuable insights into the broader role of CCCH-type zinc finger proteins in post-transcriptional regulation and the complex mechanisms governing RNA metabolism and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
This compound inhibits cyclin-dependent kinases (CDKs), which are essential for cell cycle progression. Inhibition of CDKs could affect the RNA processing and export in the nucleus, where ZC3H14 is known to play a role by binding to polyadenylated RNA, potentially leading to decreased ZC3H14 function. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
A potent protein kinase C (PKC) inhibitor. PKC plays a role in RNA splicing, which could influence the processing of transcripts to which ZC3H14 binds, leading to its functional inhibition. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine kinase inhibitor that raises the levels of adenosine, potentially impacting RNA processing and metabolism. ZC3H14 is involved in RNA binding and its inhibition could affect ZC3H14's function. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
A splicing inhibitor that targets the spliceosome, a complex involved in RNA splicing. ZC3H14 interacts with the polyadenylated RNA, and its functional inhibition may result from disruptions in splicing machinery. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
This compound is a specific inhibitor of the spliceosomal SF3b complex. By impacting splicing, it could indirectly inhibit ZC3H14's function related to RNA binding and regulation. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A biflavonoid that inhibits splicing. ZC3H14, functioning in RNA binding, could be functionally inhibited due to alterations in pre-mRNA splicing caused by this compound. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
A splicing inhibitor targeting the SF3b complex. By affecting RNA splicing, it could indirectly inhibit the function of ZC3H14 in RNA metabolism. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Disrupts splicing by targeting the spliceosome. This could indirectly inhibit ZC3H14's function since it is involved in RNA processing. | ||||||